Arene Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 75.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 34.40 Cr
as on 26-06-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 128.24 Cr
as on 26-06-2024
- Satisfied Charges ₹ 17.00 Cr
as on 26-06-2024
- Revenue -14.71%
(FY 2023)
- Profit -69.18%
(FY 2023)
- Ebitda -55.67%
(FY 2023)
- Net Worth 4.53%
(FY 2023)
- Total Assets 9.59%
(FY 2023)
About Arene Life Sciences
The Corporate was formerly known as Arene Life Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 75.00 Cr and a paid-up capital of Rs 34.40 Cr.
The company currently has active open charges totaling ₹128.24 Cr. The company has closed loans amounting to ₹17.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Arene Life Sciences Private Limited India is Satyanarayana Chinnamail as CFO. Santosh Chinnamail, Satyanarayana Chinnamail, Khairtabad Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC044199
- Company No.
044199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Sangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arene Life Sciences Private Limited offer?
Arene Life Sciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Pharma Ingredients & Raw Materials, Anti Infective API, Organic and Inorganic Solvents, Ketones, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Medical Treatment Services.
Who are the key members and board of directors at Arene Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Chinnamail  | CFO | 01-Oct-2014 | Current |
| Satyanarayana Khairtabad | Managing Director | 17-Sep-2004 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Chinnamail | Director | 06-Sep-2019 | Current |
| Satyanarayana Chinnamail | Director and Cfo | 17-Sep-2004 | Current |
| Khairtabad Reddy | Director | 06-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Arene Life Sciences.
Arene Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.71% decrease. The company also saw a substantial fall in profitability, with a 69.18% decrease in profit. The company's net worth moved up by a moderate rise of 4.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arene Life Sciences?
In 2023, Arene Life Sciences had a promoter holding of 96.54% and a public holding of 3.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arene Life Sciences (Unit 3) Private LimitedActive 18 years 10 monthsSantosh Chinnamail, Satyanarayana Chinnamail and 2 more are mutual person
- S.R. Drugs And Intermediates Pvt.Ltd.Active 32 years 2 months
Satyanarayana Chinnamail and Satyanarayana Khairtabad are mutual person
- S.R. Drugs And Intermediates (Unit 3) Private LimitedActive 4 years 6 months
Satyanarayana Chinnamail and Satyanarayana Khairtabad are mutual person
- S.R. Drugs And Intermediates (Unit 2) Private LimitedActive 4 years 6 months
Satyanarayana Chinnamail and Satyanarayana Khairtabad are mutual person
Arene Life Sciences (Unit 4) Private LimitedActive 3 years 7 monthsSatyanarayana Chinnamail and Satyanarayana Khairtabad are mutual person
Srduo Infra LlpActive 4 years 9 monthsSatyanarayana Chinnamail and Satyanarayana Khairtabad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Dec 2023 | ₹2.23 M | Open |
Others Creation Date: 31 Aug 2023 | ₹20.00 Cr | Open |
Karnataka Bank Ltd. Creation Date: 30 Dec 2021 | ₹8.90 Cr | Open |
How Many Employees Work at Arene Life Sciences?
Arene Life Sciences has a workforce of 593 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arene Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
